Reports Produced by Inpart 7 Jan 2025Partnering 2030: Biopharma Report Download Inpart’s latest report to hear from biotechs and out-licensors, following this year’s Partnering 2030 survey. The report includes real-world partnering experiences, challenges, and insights into working with top pharmaceutical firms. January 7, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
News and Trends 2 Jan 2025 A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK. January 2, 2025 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2024 Top biotech deals of November 2024 November has seen a variety of biotech deals take place to advance therapies across different stages in development. December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Nov 2024 Six antisense oligonucleotide companies shaping the future of genetic medicine Learn more about six antisense oligonucleotide companies shaping the future of genetic medicine, just as the market is expected to grow. November 28, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 15 Nov 2024 How biotech startups become unicorns Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation. November 15, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2024 Top biotech deals of October 2024 Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024. November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Oct 2024 Six biotech companies advancing multiple sclerosis therapies Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease. October 24, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 8 Oct 2024 Top biotech deals of September 2024 There were a number of deals that stirred the biopharma industry in September. We have listed the major collaborations that took place last month. October 8, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2024 The race for a bird flu vaccine: milestones and breakthroughs The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak. September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Sep 2024 Europe’s rising biotech stars: 10 startups to watch in 2024 The European biotech industry is bustling with activity this year. Here’s a list of 10 European biotech companies likely to make a big splash. September 26, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Sep 2024 How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ’90s. September 25, 2024 - 9 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
In Depth 24 Sep 2024 New partnership model on the rise: how VCs are helping Pharma hunt for their next blockbuster Discover how the recent Pfizer-Flagship alliance model sets a trend in pharma-VC partnerships, fostering innovation in drug development. September 24, 2024 - 9 minutesmins - By Monica Karpinski Share WhatsApp Twitter Linkedin Email